INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,663 | -94.6% | 58,260 | -93.8% | 0.00% | -100.0% |
| Q2 2023 | $421,581 | +30.4% | 944,190 | +139.5% | 0.00% | +100.0% |
| Q1 2023 | $323,301 | +94.8% | 394,270 | +310.1% | 0.00% | 0.0% |
| Q3 2022 | $166,000 | -53.6% | 96,137 | -53.5% | 0.00% | -66.7% |
| Q2 2022 | $358,000 | +302.2% | 206,767 | +735.8% | 0.00% | +200.0% |
| Q1 2022 | $89,000 | -79.5% | 24,738 | -71.6% | 0.00% | -66.7% |
| Q4 2021 | $434,000 | +1176.5% | 86,996 | +753.1% | 0.00% | +200.0% |
| Q4 2019 | $34,000 | – | 10,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |